Disclaimer: This article was published in 2021 and reflects the information available at that time.
  There are certain medications that appear in notifications to PDL frequently. While some of these medications are considered low risk and have less potential for harm, it is important for pharmacists to remain vigilant when checking all prescriptions. Here are some examples of medications that have recently seen an increase in reports to PDL. Ozempic injections Ozempicâ„¢ is a non-insulin injectable used to treat Type 2 diabetes in adults 18 years and above. Since semaglutide induces side effects on initiation, lower doses are required for at least the first four weeks of use….

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more
2024-2025 most reported medicines
8 October 2025
National
Learn more